Unfortunately good science is just the first leg to commercialisation.
For everyone wondering whether the market is right or wrong and what are the causes of the sp fall. Here's one perspective given to me by an insto adviser. The science may be excellent but CU6 lost the opportunity to demonstrate the science when the FDA disallowed a head to head comparison. And while a local Australian hospital (with affiliations) is attempting to do a study, this means little internationally. He believed a local study smelt of desperation by AT. The view given was that with the long lead time to commercialisation, other products and domination of the industry by BP would neuter the great science. The other point he made was that AT had also hung his hat on a cheaper product and this is also no longer valid.
As a believer in the science and a holder I hoped he was wrong. The price was around $7 at the time and falling.
CU6 Price at posting:
$2.85 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)